LORI IZABAL: Open Payments
NPI 1114992328 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$533 in 22 payments from 11 companies in 2025. Trend: 2023 $854 · 2024 $622 · 2025 $533
Food & beverage: $533
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $101 |
| AstraZeneca Pharmaceuticals LP | 4 | $99 |
| ABBVIE INC. | 3 | $75 |
| Amgen Inc. | 2 | $57 |
| SANOFI PASTEUR INC. | 1 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Astellas Pharma US Inc | 1 | $27 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Acella Pharmaceuticals, LLC | 1 | $22 |
Products named: AIRSUPRA, UBRELVY, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, Wegovy, MOUNJARO, EMGALITY, OTEZLA, ZORYVE.
Industry payments across CA — which companies pay providers there.
